EFSA Approves the Safety of Bacillolysin Food Enzyme
On July 4, 2024, the European Food Safety Authority (EFSA) issued an official opinion on the safety evaluation of the food enzyme bacillolysin (EC 3.4.24.28).
According to reliable information, this food enzyme is produced by Amano Enzyme Inc. using the non-genetically modified Bacillus strain AE-NP, intended for application in 15 food manufacturing processes.
After a thorough assessment, the expert panel concluded that the food enzyme is not of safety concern under the intended conditions of use. Some key details from the initial assessment report are as follows:
The food enzyme was initially evaluated for safety in 13 food manufacturing processes, and EFSA confirmed that its use does not raise safety concerns. The applicant then submitted a request to extend the use of the enzyme to two additional food manufacturing processes. In this latest assessment, EFSA updated the safety evaluation of the food enzyme for its use in a total of 15 food manufacturing processes. Since two of the processes can remove the total organic solids (TOS) from the food enzyme, the dietary exposure assessment was only conducted for the remaining 13 processes. Based on the data provided in the previous assessment and the revised dietary exposure estimates in this assessment, the expert panel concluded that the food enzyme is not of safety concern under the revised intended conditions of use. The estimated dietary exposure for the European population was calculated to be up to 35.251 mg TOS/kg body weight per day.
Looking for chemical products? Let suppliers reach out to you!
2026-07-03
-
Functional Ingredients Industry Overview
Collection of Markets for Functional Ingredients in Food & Nutrition and Cosmetics.Published in: Mar. 2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
FDA Color Policy Uncertainty Opens a New Chapter for Food Ingredient Reform
-
EFSA Raises Neotame Safety Limit by 5 Times Confirms No Health Risks
-
Maine’s Cozy Harbor Seafood Files Chapter 11 Bankruptcy Owes Over $5 Million
-
SML Launches 2 Breakthrough Bioproducts to Boost Indian Crop Yields Amid Climate Change
-
Allterra Targets 17 Billion BRL Market with Three New Bioproducts for Soil Health
-
New York’s Additive Ban Signals a Tougher Era for Food Formulation
-
FDA’s Review of BHT and ADA Signals a New Era for Food Additive Compliance
-
FDA Dye Phase-Out Push Opens a Bigger Window for Natural Color Solutions
-
EFSA Deems Extended Use of Bacillolysin Enzyme Safe
-
EFSA Publishes Peer Review on Fungicide Prothioconazole
Recommend Reading
-
Biochem to Acquire BASF’s Global Glycinates Business
-
FSANZ Advances Caffeine Permission Changes
-
Natural Color Claims Get Easier
-
FDA Tracks Industry Dye Removal
-
Aldi Expands Its Ingredient Ban
-
Why You Should Never Mix Bleach and Vinegar
-
Supply and Demand Tug-of-War: Melamine Market Sees Slight Upswing
-
Cost Pressures Mount as PC Market Weakens in Mid-November
-
Suppliers Hold Firm on Prices, Slight Increase in Butadiene Market in China
-
Supply-Demand Contradiction Persists, Making Weak ABS Market Conditions Hard to Reverse